New prescription plan to be expanded nationwide

Published: 2010-07-09 07:00:00

Updated: 2010-07-09 07:00:00

The Health Insurance Review and Assessment Service (HIRAS) said on July 6 that a government-imposed review of prescribed drugs will be introduced across the country from this December.

Under the planned Drug Utilization Review (DUR) system, the drug agency will examine the duplicate efficacy o...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK